The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Prognostic score for Luminal A-like breast cancer patients.
Caterina Fontanella
No relevant relationships to disclose
Stephan Gade
No relevant relationships to disclose
Gunter Von Minckwitz
No relevant relationships to disclose
Bianca Lederer
No relevant relationships to disclose
Jens U. Blohmer
No relevant relationships to disclose
Serban Dan Costa
No relevant relationships to disclose
Carsten Denkert
Stock Ownership - Sividon Diagnostics
Research Funding - Sividon Diagnostics
Holger Eidtmann
No relevant relationships to disclose
Bernd Gerber
No relevant relationships to disclose
Claus A. Hanusch
Consultant or Advisory Role - Amgen; Novartis; Pfizer; Sanofi
Joern Hilfrich
No relevant relationships to disclose
Jens Bodo Huober
No relevant relationships to disclose
Andreas Schneeweiss
Consultant or Advisory Role - Celgene; Medac; Roche
Honoraria - AstraZeneca; Celgene; Eisai; GlaxoSmithKline; Novartis; Pfizer; Roche
Research Funding - Celgene; Roche
Stefan Paepke
No relevant relationships to disclose
Christian Jackisch
No relevant relationships to disclose
Keyur Mehta
No relevant relationships to disclose
Valentina Nekljudova
No relevant relationships to disclose
Michael Untch
No relevant relationships to disclose
Sibylle Loibl
No relevant relationships to disclose